Association of circulating tumor cell gene mutations and peripheral blood lymphocyte telomere length with the frequency and severity of immune-related pneumonitis in lung cancer patients receiving cancer immunotherapy
Not Applicable
Recruiting
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000046031
- Lead Sponsor
- HO Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Those who do not consent to the research.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The frequency and severity of immune-related pneumonitis during cancer immunotherapy.
- Secondary Outcome Measures
Name Time Method